PAIR OF ACEs PROPEL MERCK, SQUIBB SALES IN 1988: ACE INHIBITORS VASOTEC AND CAPOTEN EACH REACH $1 BIL. IN GLOBAL SALES; MEVACOR APPROACHES $200 MIL. SALES